nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—PTGS2—prostate cancer	0.23	1	CbGaD
Tenoxicam—SLC22A8—Conjugated Estrogens—prostate cancer	0.0775	0.177	CbGbCtD
Tenoxicam—SLC22A8—Estradiol—prostate cancer	0.068	0.156	CbGbCtD
Tenoxicam—CYP2C9—Nilutamide—prostate cancer	0.0632	0.145	CbGbCtD
Tenoxicam—CYP2C9—Bicalutamide—prostate cancer	0.0632	0.145	CbGbCtD
Tenoxicam—PTGS2—Etoposide—prostate cancer	0.0418	0.0955	CbGbCtD
Tenoxicam—CYP2C9—Estrone—prostate cancer	0.0379	0.0866	CbGbCtD
Tenoxicam—PTGS1—Etoposide—prostate cancer	0.0353	0.0807	CbGbCtD
Tenoxicam—CYP2C9—Capecitabine—prostate cancer	0.0287	0.0656	CbGbCtD
Tenoxicam—CYP2C9—Estradiol—prostate cancer	0.0218	0.0497	CbGbCtD
Tenoxicam—SLC22A8—urine—prostate cancer	0.0043	0.245	CbGeAlD
Tenoxicam—CYP2C9—urine—prostate cancer	0.00279	0.159	CbGeAlD
Tenoxicam—SLC22A8—prostate gland—prostate cancer	0.00154	0.0879	CbGeAlD
Tenoxicam—SLC22A8—renal system—prostate cancer	0.00105	0.0599	CbGeAlD
Tenoxicam—PTGS1—prostate gland—prostate cancer	0.000915	0.0522	CbGeAlD
Tenoxicam—PTGS2—prostate gland—prostate cancer	0.000875	0.0499	CbGeAlD
Tenoxicam—Lornoxicam—PTGS2—prostate cancer	0.000792	0.353	CrCbGaD
Tenoxicam—PTGS1—seminal vesicle—prostate cancer	0.000774	0.0441	CbGeAlD
Tenoxicam—PTGS2—seminal vesicle—prostate cancer	0.00074	0.0422	CbGeAlD
Tenoxicam—PTGS1—epithelium—prostate cancer	0.000673	0.0384	CbGeAlD
Tenoxicam—PTGS2—epithelium—prostate cancer	0.000643	0.0367	CbGeAlD
Tenoxicam—PTGS1—renal system—prostate cancer	0.000624	0.0356	CbGeAlD
Tenoxicam—PTGS2—renal system—prostate cancer	0.000596	0.034	CbGeAlD
Tenoxicam—PTGS2—urethra—prostate cancer	0.000586	0.0334	CbGeAlD
Tenoxicam—Meloxicam—CYP3A4—prostate cancer	0.000514	0.229	CrCbGaD
Tenoxicam—Meloxicam—PTGS2—prostate cancer	0.000503	0.224	CrCbGaD
Tenoxicam—PTGS2—bone marrow—prostate cancer	0.000451	0.0257	CbGeAlD
Tenoxicam—Piroxicam—PTGS2—prostate cancer	0.000436	0.194	CrCbGaD
Tenoxicam—PTGS1—testis—prostate cancer	0.000403	0.023	CbGeAlD
Tenoxicam—PTGS1—lymph node—prostate cancer	0.000292	0.0167	CbGeAlD
Tenoxicam—PTGS2—lymph node—prostate cancer	0.000279	0.0159	CbGeAlD
Tenoxicam—Immune system disorder—Docetaxel—prostate cancer	0.000155	0.000753	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.000155	0.000752	CcSEcCtD
Tenoxicam—Cardiac disorder—Capecitabine—prostate cancer	0.000154	0.000749	CcSEcCtD
Tenoxicam—Decreased appetite—Mitoxantrone—prostate cancer	0.000153	0.000745	CcSEcCtD
Tenoxicam—Fatigue—Mitoxantrone—prostate cancer	0.000152	0.000739	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000152	0.000738	CcSEcCtD
Tenoxicam—Vomiting—Goserelin—prostate cancer	0.000152	0.000737	CcSEcCtD
Tenoxicam—Breast disorder—Epirubicin—prostate cancer	0.000151	0.000734	CcSEcCtD
Tenoxicam—Constipation—Mitoxantrone—prostate cancer	0.000151	0.000733	CcSEcCtD
Tenoxicam—Angiopathy—Capecitabine—prostate cancer	0.000151	0.000732	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000151	0.000732	CcSEcCtD
Tenoxicam—Rash—Goserelin—prostate cancer	0.000151	0.000731	CcSEcCtD
Tenoxicam—Dermatitis—Goserelin—prostate cancer	0.00015	0.000731	CcSEcCtD
Tenoxicam—Vomiting—Conjugated Estrogens—prostate cancer	0.00015	0.00073	CcSEcCtD
Tenoxicam—Urticaria—Estradiol—prostate cancer	0.00015	0.00073	CcSEcCtD
Tenoxicam—Mental disorder—Docetaxel—prostate cancer	0.00015	0.00073	CcSEcCtD
Tenoxicam—Immune system disorder—Capecitabine—prostate cancer	0.00015	0.000729	CcSEcCtD
Tenoxicam—Headache—Goserelin—prostate cancer	0.00015	0.000727	CcSEcCtD
Tenoxicam—Erythema—Docetaxel—prostate cancer	0.000149	0.000726	CcSEcCtD
Tenoxicam—Malnutrition—Docetaxel—prostate cancer	0.000149	0.000726	CcSEcCtD
Tenoxicam—Rash—Conjugated Estrogens—prostate cancer	0.000149	0.000724	CcSEcCtD
Tenoxicam—Dermatitis—Conjugated Estrogens—prostate cancer	0.000149	0.000724	CcSEcCtD
Tenoxicam—Headache—Conjugated Estrogens—prostate cancer	0.000148	0.00072	CcSEcCtD
Tenoxicam—Gastritis—Epirubicin—prostate cancer	0.000148	0.000719	CcSEcCtD
Tenoxicam—Anaphylactic shock—Etoposide—prostate cancer	0.000147	0.000713	CcSEcCtD
Tenoxicam—Mental disorder—Capecitabine—prostate cancer	0.000146	0.000707	CcSEcCtD
Tenoxicam—Erythema—Capecitabine—prostate cancer	0.000145	0.000703	CcSEcCtD
Tenoxicam—Malnutrition—Capecitabine—prostate cancer	0.000145	0.000703	CcSEcCtD
Tenoxicam—Asthma—Epirubicin—prostate cancer	0.000145	0.000702	CcSEcCtD
Tenoxicam—Thrombocytopenia—Etoposide—prostate cancer	0.000144	0.000698	CcSEcCtD
Tenoxicam—Skin disorder—Etoposide—prostate cancer	0.000143	0.000692	CcSEcCtD
Tenoxicam—Nausea—Goserelin—prostate cancer	0.000142	0.000689	CcSEcCtD
Tenoxicam—Nausea—Conjugated Estrogens—prostate cancer	0.000141	0.000682	CcSEcCtD
Tenoxicam—Urticaria—Mitoxantrone—prostate cancer	0.00014	0.000681	CcSEcCtD
Tenoxicam—Breast disorder—Doxorubicin—prostate cancer	0.00014	0.00068	CcSEcCtD
Tenoxicam—Anorexia—Etoposide—prostate cancer	0.00014	0.000679	CcSEcCtD
Tenoxicam—Hypersensitivity—Estradiol—prostate cancer	0.000139	0.000677	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000139	0.000677	CcSEcCtD
Tenoxicam—Eye disorder—Prednisone—prostate cancer	0.000138	0.000672	CcSEcCtD
Tenoxicam—Anaemia—Docetaxel—prostate cancer	0.000138	0.000671	CcSEcCtD
Tenoxicam—Gastritis—Doxorubicin—prostate cancer	0.000137	0.000666	CcSEcCtD
Tenoxicam—Asthenia—Estradiol—prostate cancer	0.000136	0.00066	CcSEcCtD
Tenoxicam—Angiopathy—Prednisone—prostate cancer	0.000134	0.000652	CcSEcCtD
Tenoxicam—Pruritus—Estradiol—prostate cancer	0.000134	0.000651	CcSEcCtD
Tenoxicam—Asthma—Doxorubicin—prostate cancer	0.000134	0.00065	CcSEcCtD
Tenoxicam—Leukopenia—Docetaxel—prostate cancer	0.000134	0.00065	CcSEcCtD
Tenoxicam—Anaemia—Capecitabine—prostate cancer	0.000134	0.000649	CcSEcCtD
Tenoxicam—Immune system disorder—Prednisone—prostate cancer	0.000134	0.000649	CcSEcCtD
Tenoxicam—Palpitations—Docetaxel—prostate cancer	0.000132	0.000641	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Epirubicin—prostate cancer	0.000132	0.000641	CcSEcCtD
Tenoxicam—Dyspnoea—Etoposide—prostate cancer	0.000131	0.000635	CcSEcCtD
Tenoxicam—Vertigo—Capecitabine—prostate cancer	0.00013	0.000631	CcSEcCtD
Tenoxicam—Hypersensitivity—Mitoxantrone—prostate cancer	0.00013	0.000631	CcSEcCtD
Tenoxicam—Mental disorder—Prednisone—prostate cancer	0.00013	0.00063	CcSEcCtD
Tenoxicam—Diarrhoea—Estradiol—prostate cancer	0.00013	0.000629	CcSEcCtD
Tenoxicam—Leukopenia—Capecitabine—prostate cancer	0.000129	0.000629	CcSEcCtD
Tenoxicam—Malnutrition—Prednisone—prostate cancer	0.000129	0.000626	CcSEcCtD
Tenoxicam—Erythema—Prednisone—prostate cancer	0.000129	0.000626	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000128	0.000621	CcSEcCtD
Tenoxicam—Palpitations—Capecitabine—prostate cancer	0.000128	0.000621	CcSEcCtD
Tenoxicam—Decreased appetite—Etoposide—prostate cancer	0.000128	0.000619	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Etoposide—prostate cancer	0.000127	0.000615	CcSEcCtD
Tenoxicam—Asthenia—Mitoxantrone—prostate cancer	0.000127	0.000615	CcSEcCtD
Tenoxicam—Fatigue—Etoposide—prostate cancer	0.000127	0.000614	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000126	0.000614	CcSEcCtD
Tenoxicam—Stomatitis—Epirubicin—prostate cancer	0.000126	0.00061	CcSEcCtD
Tenoxicam—Constipation—Etoposide—prostate cancer	0.000125	0.000609	CcSEcCtD
Tenoxicam—Dizziness—Estradiol—prostate cancer	0.000125	0.000608	CcSEcCtD
Tenoxicam—Dry mouth—Docetaxel—prostate cancer	0.000124	0.000604	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000122	0.000594	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000122	0.000593	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Epirubicin—prostate cancer	0.000122	0.000592	CcSEcCtD
Tenoxicam—Anaphylactic shock—Docetaxel—prostate cancer	0.000122	0.000592	CcSEcCtD
Tenoxicam—Oedema—Docetaxel—prostate cancer	0.000122	0.000592	CcSEcCtD
Tenoxicam—Diarrhoea—Mitoxantrone—prostate cancer	0.000121	0.000586	CcSEcCtD
Tenoxicam—Dry mouth—Capecitabine—prostate cancer	0.00012	0.000585	CcSEcCtD
Tenoxicam—Vomiting—Estradiol—prostate cancer	0.00012	0.000585	CcSEcCtD
Tenoxicam—Agranulocytosis—Epirubicin—prostate cancer	0.00012	0.000584	CcSEcCtD
Tenoxicam—Nervous system disorder—Docetaxel—prostate cancer	0.00012	0.000581	CcSEcCtD
Tenoxicam—Thrombocytopenia—Docetaxel—prostate cancer	0.000119	0.00058	CcSEcCtD
Tenoxicam—Rash—Estradiol—prostate cancer	0.000119	0.00058	CcSEcCtD
Tenoxicam—Dermatitis—Estradiol—prostate cancer	0.000119	0.000579	CcSEcCtD
Tenoxicam—Anaemia—Prednisone—prostate cancer	0.000119	0.000578	CcSEcCtD
Tenoxicam—Headache—Estradiol—prostate cancer	0.000119	0.000576	CcSEcCtD
Tenoxicam—Skin disorder—Docetaxel—prostate cancer	0.000118	0.000575	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000118	0.000575	CcSEcCtD
Tenoxicam—Oedema—Capecitabine—prostate cancer	0.000118	0.000573	CcSEcCtD
Tenoxicam—Angioedema—Prednisone—prostate cancer	0.000118	0.000572	CcSEcCtD
Tenoxicam—Urticaria—Etoposide—prostate cancer	0.000117	0.000566	CcSEcCtD
Tenoxicam—Stomatitis—Doxorubicin—prostate cancer	0.000116	0.000565	CcSEcCtD
Tenoxicam—Anorexia—Docetaxel—prostate cancer	0.000116	0.000565	CcSEcCtD
Tenoxicam—Nervous system disorder—Capecitabine—prostate cancer	0.000116	0.000562	CcSEcCtD
Tenoxicam—Vertigo—Prednisone—prostate cancer	0.000116	0.000562	CcSEcCtD
Tenoxicam—Hepatitis—Epirubicin—prostate cancer	0.000116	0.000562	CcSEcCtD
Tenoxicam—Thrombocytopenia—Capecitabine—prostate cancer	0.000116	0.000561	CcSEcCtD
Tenoxicam—Skin disorder—Capecitabine—prostate cancer	0.000115	0.000557	CcSEcCtD
Tenoxicam—Urinary tract disorder—Epirubicin—prostate cancer	0.000114	0.000555	CcSEcCtD
Tenoxicam—Urethral disorder—Epirubicin—prostate cancer	0.000113	0.000551	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000113	0.000548	CcSEcCtD
Tenoxicam—Anorexia—Capecitabine—prostate cancer	0.000113	0.000547	CcSEcCtD
Tenoxicam—Nausea—Estradiol—prostate cancer	0.000112	0.000546	CcSEcCtD
Tenoxicam—Vomiting—Mitoxantrone—prostate cancer	0.000112	0.000545	CcSEcCtD
Tenoxicam—Visual impairment—Epirubicin—prostate cancer	0.000112	0.000542	CcSEcCtD
Tenoxicam—Agranulocytosis—Doxorubicin—prostate cancer	0.000111	0.000541	CcSEcCtD
Tenoxicam—Rash—Mitoxantrone—prostate cancer	0.000111	0.00054	CcSEcCtD
Tenoxicam—Dermatitis—Mitoxantrone—prostate cancer	0.000111	0.00054	CcSEcCtD
Tenoxicam—Headache—Mitoxantrone—prostate cancer	0.000111	0.000537	CcSEcCtD
Tenoxicam—Erythema multiforme—Epirubicin—prostate cancer	0.000109	0.000532	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000109	0.000529	CcSEcCtD
Tenoxicam—Dyspnoea—Docetaxel—prostate cancer	0.000109	0.000528	CcSEcCtD
Tenoxicam—Eye disorder—Epirubicin—prostate cancer	0.000108	0.000525	CcSEcCtD
Tenoxicam—Hypersensitivity—Etoposide—prostate cancer	0.000108	0.000525	CcSEcCtD
Tenoxicam—Cardiac disorder—Epirubicin—prostate cancer	0.000107	0.000522	CcSEcCtD
Tenoxicam—Dyspepsia—Docetaxel—prostate cancer	0.000107	0.000521	CcSEcCtD
Tenoxicam—Hepatitis—Doxorubicin—prostate cancer	0.000107	0.00052	CcSEcCtD
Tenoxicam—Decreased appetite—Docetaxel—prostate cancer	0.000106	0.000515	CcSEcCtD
Tenoxicam—Urinary tract disorder—Doxorubicin—prostate cancer	0.000106	0.000514	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000105	0.000511	CcSEcCtD
Tenoxicam—Asthenia—Etoposide—prostate cancer	0.000105	0.000511	CcSEcCtD
Tenoxicam—Dyspnoea—Capecitabine—prostate cancer	0.000105	0.000511	CcSEcCtD
Tenoxicam—Anaphylactic shock—Prednisone—prostate cancer	0.000105	0.000511	CcSEcCtD
Tenoxicam—Oedema—Prednisone—prostate cancer	0.000105	0.000511	CcSEcCtD
Tenoxicam—Fatigue—Docetaxel—prostate cancer	0.000105	0.000511	CcSEcCtD
Tenoxicam—Angiopathy—Epirubicin—prostate cancer	0.000105	0.00051	CcSEcCtD
Tenoxicam—Urethral disorder—Doxorubicin—prostate cancer	0.000105	0.00051	CcSEcCtD
Tenoxicam—Nausea—Mitoxantrone—prostate cancer	0.000105	0.000509	CcSEcCtD
Tenoxicam—Immune system disorder—Epirubicin—prostate cancer	0.000105	0.000508	CcSEcCtD
Tenoxicam—Constipation—Docetaxel—prostate cancer	0.000104	0.000506	CcSEcCtD
Tenoxicam—Dyspepsia—Capecitabine—prostate cancer	0.000104	0.000505	CcSEcCtD
Tenoxicam—Pruritus—Etoposide—prostate cancer	0.000104	0.000504	CcSEcCtD
Tenoxicam—Visual impairment—Doxorubicin—prostate cancer	0.000103	0.000501	CcSEcCtD
Tenoxicam—Nervous system disorder—Prednisone—prostate cancer	0.000103	0.000501	CcSEcCtD
Tenoxicam—Decreased appetite—Capecitabine—prostate cancer	0.000103	0.000498	CcSEcCtD
Tenoxicam—Skin disorder—Prednisone—prostate cancer	0.000102	0.000496	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000102	0.000495	CcSEcCtD
Tenoxicam—Fatigue—Capecitabine—prostate cancer	0.000102	0.000494	CcSEcCtD
Tenoxicam—Mental disorder—Epirubicin—prostate cancer	0.000101	0.000493	CcSEcCtD
Tenoxicam—Erythema multiforme—Doxorubicin—prostate cancer	0.000101	0.000492	CcSEcCtD
Tenoxicam—Constipation—Capecitabine—prostate cancer	0.000101	0.00049	CcSEcCtD
Tenoxicam—Erythema—Epirubicin—prostate cancer	0.000101	0.000489	CcSEcCtD
Tenoxicam—Malnutrition—Epirubicin—prostate cancer	0.000101	0.000489	CcSEcCtD
Tenoxicam—Diarrhoea—Etoposide—prostate cancer	0.0001	0.000488	CcSEcCtD
Tenoxicam—Anorexia—Prednisone—prostate cancer	0.0001	0.000487	CcSEcCtD
Tenoxicam—Eye disorder—Doxorubicin—prostate cancer	0.0001	0.000486	CcSEcCtD
Tenoxicam—Cardiac disorder—Doxorubicin—prostate cancer	9.94e-05	0.000483	CcSEcCtD
Tenoxicam—Angiopathy—Doxorubicin—prostate cancer	9.72e-05	0.000472	CcSEcCtD
Tenoxicam—Dizziness—Etoposide—prostate cancer	9.7e-05	0.000471	CcSEcCtD
Tenoxicam—Immune system disorder—Doxorubicin—prostate cancer	9.68e-05	0.00047	CcSEcCtD
Tenoxicam—Mental disorder—Doxorubicin—prostate cancer	9.38e-05	0.000456	CcSEcCtD
Tenoxicam—Urticaria—Capecitabine—prostate cancer	9.38e-05	0.000456	CcSEcCtD
Tenoxicam—Vomiting—Etoposide—prostate cancer	9.33e-05	0.000453	CcSEcCtD
Tenoxicam—Erythema—Doxorubicin—prostate cancer	9.33e-05	0.000453	CcSEcCtD
Tenoxicam—Malnutrition—Doxorubicin—prostate cancer	9.33e-05	0.000453	CcSEcCtD
Tenoxicam—Anaemia—Epirubicin—prostate cancer	9.31e-05	0.000452	CcSEcCtD
Tenoxicam—Dyspepsia—Prednisone—prostate cancer	9.26e-05	0.00045	CcSEcCtD
Tenoxicam—Rash—Etoposide—prostate cancer	9.25e-05	0.000449	CcSEcCtD
Tenoxicam—Dermatitis—Etoposide—prostate cancer	9.24e-05	0.000449	CcSEcCtD
Tenoxicam—Headache—Etoposide—prostate cancer	9.19e-05	0.000446	CcSEcCtD
Tenoxicam—Decreased appetite—Prednisone—prostate cancer	9.14e-05	0.000444	CcSEcCtD
Tenoxicam—Fatigue—Prednisone—prostate cancer	9.07e-05	0.00044	CcSEcCtD
Tenoxicam—Vertigo—Epirubicin—prostate cancer	9.05e-05	0.00044	CcSEcCtD
Tenoxicam—Leukopenia—Epirubicin—prostate cancer	9.02e-05	0.000438	CcSEcCtD
Tenoxicam—Constipation—Prednisone—prostate cancer	8.99e-05	0.000437	CcSEcCtD
Tenoxicam—Hypersensitivity—Docetaxel—prostate cancer	8.98e-05	0.000436	CcSEcCtD
Tenoxicam—Palpitations—Epirubicin—prostate cancer	8.91e-05	0.000433	CcSEcCtD
Tenoxicam—Asthenia—Docetaxel—prostate cancer	8.75e-05	0.000425	CcSEcCtD
Tenoxicam—Nausea—Etoposide—prostate cancer	8.72e-05	0.000423	CcSEcCtD
Tenoxicam—Hypersensitivity—Capecitabine—prostate cancer	8.7e-05	0.000422	CcSEcCtD
Tenoxicam—Pruritus—Docetaxel—prostate cancer	8.63e-05	0.000419	CcSEcCtD
Tenoxicam—Anaemia—Doxorubicin—prostate cancer	8.62e-05	0.000419	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	8.52e-05	0.000414	CcSEcCtD
Tenoxicam—Asthenia—Capecitabine—prostate cancer	8.47e-05	0.000411	CcSEcCtD
Tenoxicam—Dry mouth—Epirubicin—prostate cancer	8.39e-05	0.000408	CcSEcCtD
Tenoxicam—Vertigo—Doxorubicin—prostate cancer	8.38e-05	0.000407	CcSEcCtD
Tenoxicam—Urticaria—Prednisone—prostate cancer	8.35e-05	0.000406	CcSEcCtD
Tenoxicam—Pruritus—Capecitabine—prostate cancer	8.35e-05	0.000406	CcSEcCtD
Tenoxicam—Leukopenia—Doxorubicin—prostate cancer	8.35e-05	0.000405	CcSEcCtD
Tenoxicam—Diarrhoea—Docetaxel—prostate cancer	8.34e-05	0.000405	CcSEcCtD
Tenoxicam—Palpitations—Doxorubicin—prostate cancer	8.24e-05	0.0004	CcSEcCtD
Tenoxicam—Anaphylactic shock—Epirubicin—prostate cancer	8.23e-05	0.000399	CcSEcCtD
Tenoxicam—Oedema—Epirubicin—prostate cancer	8.23e-05	0.000399	CcSEcCtD
Tenoxicam—Diarrhoea—Capecitabine—prostate cancer	8.08e-05	0.000392	CcSEcCtD
Tenoxicam—Nervous system disorder—Epirubicin—prostate cancer	8.07e-05	0.000392	CcSEcCtD
Tenoxicam—Dizziness—Docetaxel—prostate cancer	8.06e-05	0.000392	CcSEcCtD
Tenoxicam—Thrombocytopenia—Epirubicin—prostate cancer	8.05e-05	0.000391	CcSEcCtD
Tenoxicam—Skin disorder—Epirubicin—prostate cancer	7.99e-05	0.000388	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	7.88e-05	0.000383	CcSEcCtD
Tenoxicam—Anorexia—Epirubicin—prostate cancer	7.84e-05	0.000381	CcSEcCtD
Tenoxicam—Dizziness—Capecitabine—prostate cancer	7.81e-05	0.000379	CcSEcCtD
Tenoxicam—Dry mouth—Doxorubicin—prostate cancer	7.76e-05	0.000377	CcSEcCtD
Tenoxicam—Vomiting—Docetaxel—prostate cancer	7.75e-05	0.000377	CcSEcCtD
Tenoxicam—Hypersensitivity—Prednisone—prostate cancer	7.75e-05	0.000376	CcSEcCtD
Tenoxicam—Rash—Docetaxel—prostate cancer	7.69e-05	0.000373	CcSEcCtD
Tenoxicam—Dermatitis—Docetaxel—prostate cancer	7.68e-05	0.000373	CcSEcCtD
Tenoxicam—Headache—Docetaxel—prostate cancer	7.64e-05	0.000371	CcSEcCtD
Tenoxicam—Anaphylactic shock—Doxorubicin—prostate cancer	7.61e-05	0.00037	CcSEcCtD
Tenoxicam—Oedema—Doxorubicin—prostate cancer	7.61e-05	0.00037	CcSEcCtD
Tenoxicam—Asthenia—Prednisone—prostate cancer	7.55e-05	0.000366	CcSEcCtD
Tenoxicam—Vomiting—Capecitabine—prostate cancer	7.51e-05	0.000365	CcSEcCtD
Tenoxicam—Nervous system disorder—Doxorubicin—prostate cancer	7.46e-05	0.000362	CcSEcCtD
Tenoxicam—Thrombocytopenia—Doxorubicin—prostate cancer	7.45e-05	0.000362	CcSEcCtD
Tenoxicam—Rash—Capecitabine—prostate cancer	7.44e-05	0.000362	CcSEcCtD
Tenoxicam—Pruritus—Prednisone—prostate cancer	7.44e-05	0.000361	CcSEcCtD
Tenoxicam—Dermatitis—Capecitabine—prostate cancer	7.44e-05	0.000361	CcSEcCtD
Tenoxicam—Headache—Capecitabine—prostate cancer	7.4e-05	0.000359	CcSEcCtD
Tenoxicam—Skin disorder—Doxorubicin—prostate cancer	7.39e-05	0.000359	CcSEcCtD
Tenoxicam—Dyspnoea—Epirubicin—prostate cancer	7.33e-05	0.000356	CcSEcCtD
Tenoxicam—Anorexia—Doxorubicin—prostate cancer	7.25e-05	0.000352	CcSEcCtD
Tenoxicam—Nausea—Docetaxel—prostate cancer	7.24e-05	0.000352	CcSEcCtD
Tenoxicam—Dyspepsia—Epirubicin—prostate cancer	7.24e-05	0.000352	CcSEcCtD
Tenoxicam—Diarrhoea—Prednisone—prostate cancer	7.2e-05	0.000349	CcSEcCtD
Tenoxicam—Decreased appetite—Epirubicin—prostate cancer	7.15e-05	0.000347	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Epirubicin—prostate cancer	7.1e-05	0.000345	CcSEcCtD
Tenoxicam—Fatigue—Epirubicin—prostate cancer	7.09e-05	0.000344	CcSEcCtD
Tenoxicam—Constipation—Epirubicin—prostate cancer	7.03e-05	0.000342	CcSEcCtD
Tenoxicam—Nausea—Capecitabine—prostate cancer	7.01e-05	0.000341	CcSEcCtD
Tenoxicam—Dizziness—Prednisone—prostate cancer	6.95e-05	0.000338	CcSEcCtD
Tenoxicam—Dyspnoea—Doxorubicin—prostate cancer	6.79e-05	0.00033	CcSEcCtD
Tenoxicam—Dyspepsia—Doxorubicin—prostate cancer	6.7e-05	0.000325	CcSEcCtD
Tenoxicam—Vomiting—Prednisone—prostate cancer	6.69e-05	0.000325	CcSEcCtD
Tenoxicam—Rash—Prednisone—prostate cancer	6.63e-05	0.000322	CcSEcCtD
Tenoxicam—Dermatitis—Prednisone—prostate cancer	6.62e-05	0.000322	CcSEcCtD
Tenoxicam—Decreased appetite—Doxorubicin—prostate cancer	6.62e-05	0.000321	CcSEcCtD
Tenoxicam—Headache—Prednisone—prostate cancer	6.59e-05	0.00032	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.57e-05	0.000319	CcSEcCtD
Tenoxicam—Fatigue—Doxorubicin—prostate cancer	6.56e-05	0.000319	CcSEcCtD
Tenoxicam—Urticaria—Epirubicin—prostate cancer	6.53e-05	0.000317	CcSEcCtD
Tenoxicam—Constipation—Doxorubicin—prostate cancer	6.51e-05	0.000316	CcSEcCtD
Tenoxicam—Nausea—Prednisone—prostate cancer	6.25e-05	0.000303	CcSEcCtD
Tenoxicam—Hypersensitivity—Epirubicin—prostate cancer	6.06e-05	0.000294	CcSEcCtD
Tenoxicam—Urticaria—Doxorubicin—prostate cancer	6.05e-05	0.000294	CcSEcCtD
Tenoxicam—Asthenia—Epirubicin—prostate cancer	5.9e-05	0.000287	CcSEcCtD
Tenoxicam—Pruritus—Epirubicin—prostate cancer	5.82e-05	0.000283	CcSEcCtD
Tenoxicam—Diarrhoea—Epirubicin—prostate cancer	5.63e-05	0.000273	CcSEcCtD
Tenoxicam—Hypersensitivity—Doxorubicin—prostate cancer	5.61e-05	0.000272	CcSEcCtD
Tenoxicam—Asthenia—Doxorubicin—prostate cancer	5.46e-05	0.000265	CcSEcCtD
Tenoxicam—Dizziness—Epirubicin—prostate cancer	5.44e-05	0.000264	CcSEcCtD
Tenoxicam—Pruritus—Doxorubicin—prostate cancer	5.38e-05	0.000261	CcSEcCtD
Tenoxicam—Vomiting—Epirubicin—prostate cancer	5.23e-05	0.000254	CcSEcCtD
Tenoxicam—Diarrhoea—Doxorubicin—prostate cancer	5.21e-05	0.000253	CcSEcCtD
Tenoxicam—Rash—Epirubicin—prostate cancer	5.19e-05	0.000252	CcSEcCtD
Tenoxicam—Dermatitis—Epirubicin—prostate cancer	5.18e-05	0.000252	CcSEcCtD
Tenoxicam—Headache—Epirubicin—prostate cancer	5.15e-05	0.00025	CcSEcCtD
Tenoxicam—Dizziness—Doxorubicin—prostate cancer	5.03e-05	0.000244	CcSEcCtD
Tenoxicam—Nausea—Epirubicin—prostate cancer	4.89e-05	0.000237	CcSEcCtD
Tenoxicam—Vomiting—Doxorubicin—prostate cancer	4.84e-05	0.000235	CcSEcCtD
Tenoxicam—Rash—Doxorubicin—prostate cancer	4.8e-05	0.000233	CcSEcCtD
Tenoxicam—Dermatitis—Doxorubicin—prostate cancer	4.79e-05	0.000233	CcSEcCtD
Tenoxicam—Headache—Doxorubicin—prostate cancer	4.77e-05	0.000232	CcSEcCtD
Tenoxicam—Nausea—Doxorubicin—prostate cancer	4.52e-05	0.00022	CcSEcCtD
Tenoxicam—PTGS2—Metabolism—LRP2—prostate cancer	1.74e-05	0.000162	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP2C18—prostate cancer	1.74e-05	0.000162	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—P4HB—prostate cancer	1.7e-05	0.000159	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP7B1—prostate cancer	1.7e-05	0.000159	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—MTAP—prostate cancer	1.7e-05	0.000159	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—AKR1C3—prostate cancer	1.7e-05	0.000159	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PRKACB—prostate cancer	1.69e-05	0.000158	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP17A1—prostate cancer	1.68e-05	0.000157	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.67e-05	0.000156	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.67e-05	0.000156	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SULT1E1—prostate cancer	1.66e-05	0.000155	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SRD5A1—prostate cancer	1.66e-05	0.000155	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SLC22A1—prostate cancer	1.66e-05	0.000155	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.65e-05	0.000155	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TGFBR1—prostate cancer	1.64e-05	0.000153	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—B2M—prostate cancer	1.64e-05	0.000153	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.64e-05	0.000153	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SULT2A1—prostate cancer	1.62e-05	0.000151	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.62e-05	0.000151	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—AKR1C3—prostate cancer	1.61e-05	0.000151	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—RPS19—prostate cancer	1.61e-05	0.000151	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.61e-05	0.000151	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PRKACB—prostate cancer	1.61e-05	0.00015	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NCOA2—prostate cancer	1.6e-05	0.000149	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—MED12—prostate cancer	1.59e-05	0.000149	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.59e-05	0.000149	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ACSL4—prostate cancer	1.58e-05	0.000148	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—HSD17B3—prostate cancer	1.58e-05	0.000148	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GNG5—prostate cancer	1.58e-05	0.000147	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.57e-05	0.000146	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PPP3CA—prostate cancer	1.57e-05	0.000146	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SLC5A5—prostate cancer	1.52e-05	0.000142	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NCOA3—prostate cancer	1.52e-05	0.000142	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—UMPS—prostate cancer	1.52e-05	0.000142	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ARG2—prostate cancer	1.52e-05	0.000142	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PHGDH—prostate cancer	1.52e-05	0.000142	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PRKCZ—prostate cancer	1.51e-05	0.000142	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.51e-05	0.000141	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.49e-05	0.00014	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—LDHB—prostate cancer	1.49e-05	0.000139	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP2E1—prostate cancer	1.49e-05	0.000139	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CALR—prostate cancer	1.49e-05	0.000139	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NQO1—prostate cancer	1.47e-05	0.000138	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGFR4—prostate cancer	1.46e-05	0.000137	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PARP1—prostate cancer	1.46e-05	0.000137	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP3A5—prostate cancer	1.46e-05	0.000137	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—TH—prostate cancer	1.45e-05	0.000136	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—HPGDS—prostate cancer	1.45e-05	0.000135	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CALCA—prostate cancer	1.44e-05	0.000135	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.44e-05	0.000135	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP2C19—prostate cancer	1.44e-05	0.000135	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP3A4—prostate cancer	1.44e-05	0.000134	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.43e-05	0.000133	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PDHA1—prostate cancer	1.41e-05	0.000132	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—TCN2—prostate cancer	1.41e-05	0.000132	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTA3—prostate cancer	1.41e-05	0.000132	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—UCP3—prostate cancer	1.41e-05	0.000132	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP1B1—prostate cancer	1.41e-05	0.000132	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ACHE—prostate cancer	1.41e-05	0.000131	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTT1—prostate cancer	1.41e-05	0.000131	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP2A6—prostate cancer	1.39e-05	0.00013	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HSPA1A—prostate cancer	1.38e-05	0.000129	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.38e-05	0.000129	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GGT1—prostate cancer	1.37e-05	0.000128	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.36e-05	0.000128	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—AKR1C3—prostate cancer	1.35e-05	0.000126	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—HSD3B1—prostate cancer	1.35e-05	0.000126	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC22A3—prostate cancer	1.35e-05	0.000126	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NCOA1—prostate cancer	1.35e-05	0.000126	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PRKACB—prostate cancer	1.34e-05	0.000126	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP17A1—prostate cancer	1.33e-05	0.000124	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CASP9—prostate cancer	1.33e-05	0.000124	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP19A1—prostate cancer	1.33e-05	0.000124	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.31e-05	0.000123	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.31e-05	0.000122	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTA4—prostate cancer	1.29e-05	0.000121	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—TBXAS1—prostate cancer	1.29e-05	0.000121	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PRKCQ—prostate cancer	1.29e-05	0.00012	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—RXRA—prostate cancer	1.28e-05	0.00012	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NCOA2—prostate cancer	1.27e-05	0.000119	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.26e-05	0.000118	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTA2—prostate cancer	1.26e-05	0.000118	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.25e-05	0.000116	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SULT1A1—prostate cancer	1.24e-05	0.000116	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ABCG5—prostate cancer	1.24e-05	0.000116	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—COMT—prostate cancer	1.23e-05	0.000115	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTP1—prostate cancer	1.23e-05	0.000115	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGF10—prostate cancer	1.22e-05	0.000114	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTA1—prostate cancer	1.21e-05	0.000113	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SLC5A5—prostate cancer	1.21e-05	0.000113	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ITPR1—prostate cancer	1.21e-05	0.000113	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—HSD3B2—prostate cancer	1.2e-05	0.000112	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NAT2—prostate cancer	1.2e-05	0.000112	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTO1—prostate cancer	1.2e-05	0.000112	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.19e-05	0.000111	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP2E1—prostate cancer	1.18e-05	0.00011	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NQO1—prostate cancer	1.17e-05	0.000109	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TGFBR2—prostate cancer	1.16e-05	0.000109	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.15e-05	0.000108	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—TH—prostate cancer	1.15e-05	0.000108	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP2C18—prostate cancer	1.15e-05	0.000108	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—LRP2—prostate cancer	1.15e-05	0.000108	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PLCB2—prostate cancer	1.15e-05	0.000108	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ITPR1—prostate cancer	1.14e-05	0.000107	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.14e-05	0.000107	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—TYMS—prostate cancer	1.14e-05	0.000107	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP3A4—prostate cancer	1.14e-05	0.000106	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—P4HB—prostate cancer	1.13e-05	0.000106	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTM1—prostate cancer	1.13e-05	0.000105	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP1B1—prostate cancer	1.12e-05	0.000105	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—LPL—prostate cancer	1.11e-05	0.000103	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC22A1—prostate cancer	1.1e-05	0.000103	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.09e-05	0.000101	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GGT1—prostate cancer	1.08e-05	0.000101	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SULT2A1—prostate cancer	1.07e-05	0.0001	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP1A1—prostate cancer	1.07e-05	9.99e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NCOA1—prostate cancer	1.07e-05	9.99e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ERCC2—prostate cancer	1.06e-05	9.91e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP19A1—prostate cancer	1.05e-05	9.84e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—MED12—prostate cancer	1.05e-05	9.84e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—LPL—prostate cancer	1.05e-05	9.81e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GNG5—prostate cancer	1.04e-05	9.76e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PDGFRB—prostate cancer	1.04e-05	9.72e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—RXRA—prostate cancer	1.02e-05	9.5e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NCOA3—prostate cancer	1.01e-05	9.4e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ERCC2—prostate cancer	1.01e-05	9.4e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—MTHFR—prostate cancer	9.97e-06	9.32e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	9.89e-06	9.24e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.89e-06	9.24e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ERBB3—prostate cancer	9.83e-06	9.19e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGFR2—prostate cancer	9.82e-06	9.17e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—COMT—prostate cancer	9.79e-06	9.15e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PPARA—prostate cancer	9.78e-06	9.14e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTP1—prostate cancer	9.75e-06	9.11e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—HPGDS—prostate cancer	9.6e-06	8.97e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ITPR1—prostate cancer	9.59e-06	8.96e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP2C19—prostate cancer	9.54e-06	8.91e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MTHFR—prostate cancer	9.45e-06	8.83e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.43e-06	8.81e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TERT—prostate cancer	9.42e-06	8.81e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTT1—prostate cancer	9.31e-06	8.7e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ACHE—prostate cancer	9.31e-06	8.7e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP2A6—prostate cancer	9.2e-06	8.6e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CAV1—prostate cancer	9.2e-06	8.59e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	9.17e-06	8.57e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—TYMS—prostate cancer	9.06e-06	8.47e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HIF1A—prostate cancer	9.01e-06	8.42e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTM1—prostate cancer	8.96e-06	8.37e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—AKR1C3—prostate cancer	8.95e-06	8.37e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PRKACB—prostate cancer	8.91e-06	8.32e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP17A1—prostate cancer	8.81e-06	8.24e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—LPL—prostate cancer	8.79e-06	8.21e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.79e-06	8.21e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CAV1—prostate cancer	8.72e-06	8.15e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	8.69e-06	8.12e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP1A1—prostate cancer	8.49e-06	7.93e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ERCC2—prostate cancer	8.42e-06	7.87e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NCOA2—prostate cancer	8.4e-06	7.85e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CG—prostate cancer	8.38e-06	7.83e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—BAD—prostate cancer	8.2e-06	7.66e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC5A5—prostate cancer	8.01e-06	7.49e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—APC—prostate cancer	7.94e-06	7.42e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—INS—prostate cancer	7.93e-06	7.41e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—MTHFR—prostate cancer	7.91e-06	7.4e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—IRS1—prostate cancer	7.85e-06	7.33e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—EGF—prostate cancer	7.85e-06	7.33e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP2E1—prostate cancer	7.83e-06	7.31e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CREBBP—prostate cancer	7.77e-06	7.26e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PPARA—prostate cancer	7.76e-06	7.26e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NQO1—prostate cancer	7.74e-06	7.23e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—TH—prostate cancer	7.63e-06	7.13e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—GSK3B—prostate cancer	7.62e-06	7.12e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.58e-06	7.08e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP3A4—prostate cancer	7.55e-06	7.05e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—INS—prostate cancer	7.52e-06	7.02e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	7.51e-06	7.02e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP1B1—prostate cancer	7.42e-06	6.93e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CD—prostate cancer	7.36e-06	6.88e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CREBBP—prostate cancer	7.36e-06	6.88e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CAV1—prostate cancer	7.3e-06	6.82e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GGT1—prostate cancer	7.18e-06	6.71e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NCOA1—prostate cancer	7.08e-06	6.61e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MAP2K1—prostate cancer	7.03e-06	6.57e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3CD—prostate cancer	6.98e-06	6.52e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP19A1—prostate cancer	6.97e-06	6.52e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.97e-06	6.52e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NOS3—prostate cancer	6.95e-06	6.5e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SERPINE1—prostate cancer	6.9e-06	6.45e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—RXRA—prostate cancer	6.73e-06	6.29e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGF2—prostate cancer	6.68e-06	6.25e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CG—prostate cancer	6.65e-06	6.21e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NOS3—prostate cancer	6.59e-06	6.16e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.55e-06	6.12e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—COMT—prostate cancer	6.48e-06	6.06e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTP1—prostate cancer	6.45e-06	6.03e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CB—prostate cancer	6.42e-06	6e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—JAK2—prostate cancer	6.41e-06	5.99e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PTGS2—prostate cancer	6.36e-06	5.94e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ITPR1—prostate cancer	6.35e-06	5.93e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—INS—prostate cancer	6.29e-06	5.88e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MDM2—prostate cancer	6.25e-06	5.84e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.24e-06	5.83e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CREBBP—prostate cancer	6.17e-06	5.76e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ERBB2—prostate cancer	6.17e-06	5.76e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3CB—prostate cancer	6.08e-06	5.69e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—TYMS—prostate cancer	6e-06	5.61e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTM1—prostate cancer	5.93e-06	5.54e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CD—prostate cancer	5.85e-06	5.46e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—LPL—prostate cancer	5.82e-06	5.44e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN1B—prostate cancer	5.71e-06	5.34e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP1A1—prostate cancer	5.62e-06	5.25e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ERCC2—prostate cancer	5.58e-06	5.21e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PTEN—prostate cancer	5.55e-06	5.18e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NOS3—prostate cancer	5.52e-06	5.16e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CTNNB1—prostate cancer	5.39e-06	5.04e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—EP300—prostate cancer	5.29e-06	4.94e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN1A—prostate cancer	5.27e-06	4.92e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PTEN—prostate cancer	5.26e-06	4.91e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—MTHFR—prostate cancer	5.24e-06	4.9e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PPARA—prostate cancer	5.14e-06	4.81e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CB—prostate cancer	5.1e-06	4.76e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—EP300—prostate cancer	5.01e-06	4.69e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SRC—prostate cancer	4.88e-06	4.56e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CAV1—prostate cancer	4.83e-06	4.52e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—STAT3—prostate cancer	4.7e-06	4.39e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.62e-06	4.32e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CG—prostate cancer	4.4e-06	4.12e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PTEN—prostate cancer	4.4e-06	4.11e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MYC—prostate cancer	4.37e-06	4.08e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TGFB1—prostate cancer	4.36e-06	4.07e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—EGFR—prostate cancer	4.27e-06	3.99e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—EP300—prostate cancer	4.2e-06	3.92e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—INS—prostate cancer	4.17e-06	3.9e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CREBBP—prostate cancer	4.08e-06	3.82e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—KRAS—prostate cancer	4.04e-06	3.77e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CA—prostate cancer	3.91e-06	3.66e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CD—prostate cancer	3.87e-06	3.62e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3CA—prostate cancer	3.71e-06	3.47e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NOS3—prostate cancer	3.66e-06	3.42e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CB—prostate cancer	3.37e-06	3.15e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTGS2—prostate cancer	3.34e-06	3.12e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—IL6—prostate cancer	3.28e-06	3.07e-05	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—AKT1—prostate cancer	3.2e-06	2.99e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CA—prostate cancer	3.11e-06	2.9e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—AKT1—prostate cancer	3.03e-06	2.83e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTEN—prostate cancer	2.92e-06	2.72e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—EP300—prostate cancer	2.78e-06	2.6e-05	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—AKT1—prostate cancer	2.54e-06	2.37e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.06e-06	1.92e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—AKT1—prostate cancer	1.68e-06	1.57e-05	CbGpPWpGaD
